Beatriz Rey-Búa

5PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 31, 2025
Impact of the kinetics of circulating anti-BCMA CAR-T cells and normal lymphocytes on the outcome of MM patients.

Sara Gutiérrez-Herrero, Lourdes Martín-Martín, María Herrero-García

|Jun 27, 2024
Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma.

Cristina Agulló, Noemí Puig, Teresa Contreras

|Jun 20, 2024
Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group.

Beatriz Rey-Búa, Carlos Grande, José J Sánchez Blanco

|May 08, 2024
A research center's experience of T-cell-redirecting therapies in triple-class refractory multiple myeloma.

Borja Puertas, Adolfo Fernández-Sánchez, Elena Alejo

|Nov 26, 2022
Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups.

Beatriz Rey-Búa, Mónica Cabrero, Leyre Bento

Pageof 1

Frequent Collaborators

3 joint publications

María-Victoria Mateos

3 joint publications

Verónica González-Calle

2 joint publications

Alejandro Martín García-Sancho

2 joint publications

Estefanía Pérez-López